510(k) K201217
K201217 is an FDA 510(k) premarket notification submitted by Hemocue AB for the device "HemoCue Hb 301 System". The FDA issued a decision of Substantially Equivalent on August 4, 2020. The device falls under product code GKR (System, Hemoglobin, Automated), a Class II device regulated under 21 CFR 864.5620. Hemocue AB has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 4, 2020
- Date Received
- May 6, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Hemoglobin, Automated
- Device Class
- Class II
- Regulation Number
- 864.5620
- Review Panel
- HE
- Submission Type